Palvella Cash Conversion Cycle from 2010 to 2026
| PVLA Stock | 78.71 5.26 6.26% |
Cash Conversion Cycle | First Reported 2010-12-31 | Previous Quarter (375.88) | Current Value (394.68) | Quarterly Volatility 415.19507025 |
Check Palvella Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Palvella Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.4 M, Interest Expense of 5.2 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.42, Dividend Yield of 0.0 or PTB Ratio of 0.52. Palvella financial statements analysis is a perfect complement when working with Palvella Therapeutics Valuation or Volatility modules.
Palvella | Cash Conversion Cycle | Build AI portfolio with Palvella Stock |
Latest Palvella Therapeutics' Cash Conversion Cycle Growth Pattern
Below is the plot of the Cash Conversion Cycle of Palvella Therapeutics over the last few years. It is Palvella Therapeutics' Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Palvella Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Cash Conversion Cycle | 10 Years Trend |
|
Cash Conversion Cycle |
| Timeline |
Palvella Cash Conversion Cycle Regression Statistics
| Arithmetic Mean | (1,029) | |
| Coefficient Of Variation | (40.37) | |
| Mean Deviation | 366.97 | |
| Median | (1,288) | |
| Standard Deviation | 415.20 | |
| Sample Variance | 172,387 | |
| Range | 913 | |
| R-Value | 0.79 | |
| Mean Square Error | 68,253 | |
| R-Squared | 0.63 | |
| Significance | 0.0001 | |
| Slope | 65.20 | |
| Total Sum of Squares | 2.8M |
Palvella Cash Conversion Cycle History
About Palvella Therapeutics Financial Statements
Palvella Therapeutics stakeholders use historical fundamental indicators, such as Palvella Therapeutics' Cash Conversion Cycle, to determine how well the company is positioned to perform in the future. Although Palvella Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Palvella Therapeutics' assets and liabilities are reflected in the revenues and expenses on Palvella Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Palvella Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash Conversion Cycle | (375.88) | (394.68) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Palvella Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Palvella Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Palvella Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Palvella Therapeutics Stock:Check out the analysis of Palvella Therapeutics Correlation against competitors. For information on how to trade Palvella Stock refer to our How to Trade Palvella Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palvella Therapeutics. Anticipated expansion of Palvella directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Palvella Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Palvella Therapeutics is measured differently than its book value, which is the value of Palvella that is recorded on the company's balance sheet. Investors also form their own opinion of Palvella Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Palvella Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palvella Therapeutics' market value can be influenced by many factors that don't directly affect Palvella Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Palvella Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Palvella Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Palvella Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.